Literature DB >> 8838229

Enzymatic and molecular diagnosis of Gaucher disease.

J A Barranger1, E Rice, S A Sakallah, C Sansieri, T E Mifflin, D L Cooper.   

Abstract

Advances in the knowledge of the molecular genetics of Gaucher disease has made diagnosis more certain. Carrier detection in kindreds in which the responsible mutation has been defined is completely reliable now. Coupled with enzymatic assays, the diagnostic capabilities are greater than before. Use of these methods provides important information to individuals at risk and allows them to make critical decisions. The new, simplified methods reviewed in this article permit the molecular diagnosis of the disease and carrier stage of large numbers of samples within 1 week.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8838229

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  2 in total

Review 1.  Lessons learned from the development of enzyme therapy for Gaucher disease.

Authors:  J A Barranger; E O'Rourke
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

2.  Clinical and genetic characteristics of Gaucher disease according to phenotypic subgroups.

Authors:  Ju-Young Lee; Beom Hee Lee; Gu-Hwan Kim; Chang-Woo Jung; Jin Lee; Jin-Ho Choi; Han-Wook Yoo
Journal:  Korean J Pediatr       Date:  2012-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.